Shannon Entropy Mapping -AF Ablation From First Principles
Funder
National Health and Medical Research Council
Funding Amount
$263,503.00
Summary
Atrial fibrillation (AF) is the most common heart rhythm disorder in humans, and a rapidly growing epidemic in Australia. AF occurs because electrical circuits called rotors take over the top chambers of the heart. Until now, ablation procedures to target AF have not been able to specifically target rotors, which has meant operations are often long and arduous. This project uses new mathematical techniques we have developed to localise rotors driving AF, aiming to develop a faster safer and more ....Atrial fibrillation (AF) is the most common heart rhythm disorder in humans, and a rapidly growing epidemic in Australia. AF occurs because electrical circuits called rotors take over the top chambers of the heart. Until now, ablation procedures to target AF have not been able to specifically target rotors, which has meant operations are often long and arduous. This project uses new mathematical techniques we have developed to localise rotors driving AF, aiming to develop a faster safer and more effective AF ablation.Read moreRead less
Shannon Entropy Mapping - AF Ablation From First Principles
Funder
National Health and Medical Research Council
Funding Amount
$439,589.00
Summary
Atrial fibrillation (AF) is the most common heart rhythm disorder in humans, and a rapidly growing epidemic in Australia. AF occurs because electrical circuits called rotors take over the top chambers of the heart. Until now, ablation procedures to target AF have not been able to specifically target rotors, which has meant operations are often long and arduous. This project uses new mathematical techniques we have developed to localise rotors driving AF, aiming to develop a faster safer and more ....Atrial fibrillation (AF) is the most common heart rhythm disorder in humans, and a rapidly growing epidemic in Australia. AF occurs because electrical circuits called rotors take over the top chambers of the heart. Until now, ablation procedures to target AF have not been able to specifically target rotors, which has meant operations are often long and arduous. This project uses new mathematical techniques we have developed to localise rotors driving AF, aiming to develop a faster safer and more effective AF ablation.Read moreRead less
Electrophysiologic Phenotyping Of Non Ischaemic Cardiomyopathy To Predict Clinical Outcome
Funder
National Health and Medical Research Council
Funding Amount
$374,676.00
Summary
Non-ischemic cardiomyopathy (NICM) is a common cause of heart failure and sudden death. Currently, the guidelines for the management are generalised and do not differentiate patients at high risk of disease progression and sudden death. This project aims to identify the electrical and structural properties of heart, to predict the clinical course in patients with NICM. Identification of high-risk patients will help allocate resources wisely and enable appropriate patient counselling.
Better Care Of Heart And Lung Disease For Aboriginal And Torres Strait Islander People In Rural And Remote Australia
Funder
National Health and Medical Research Council
Funding Amount
$380,583.00
Summary
Lung and heart disease are major contributors to the Aboriginal Australian and Torres Strait Islander health gap. This is even more so in remote and regional Australia. This Fellowship will generate new knowledge regarding how best to prevent, diagnose and treat heart and lung disease in this setting. Based in Alice Springs, it will bring together researchers and health care providers across northern and Central Australia and link them with our leading national research institutes.
NOVEL NON-INVASIVE METHODS FOR THE EARLY DETECTION OF PULMONARY VASCULAR DISEASE
Funder
National Health and Medical Research Council
Funding Amount
$320,463.00
Summary
Pulmonary arterial hypertension (PAH) is a severe, progressive disorder. Current non-invasive diagnostic modalities are insensitive for detecting early disease, thus preventing early intervention with therapy. We aim to develop novel and reproducible ways to assess the pulmonary circulation, which will ultimately allow for the early diagnosis of PAH and in turn facilitate early initiation of treatment and improved patient outcomes.
Revealing The Roadblocks: Timely ST-segment Elevation Myocardial Infarction (STEMI) Management Over Total Ischaemic Time In Metropolitan, Regional And Rural Victoria.
Funder
National Health and Medical Research Council
Funding Amount
$72,768.00
Summary
Cardiovascular disease kills one Australian every 12 minutes. Coordinated and prompt medical treatment of heart attack is essential in preventing mortality. This study will identify contributing factors of delay from a frontline clinician and hospital perspective. It is anticipated by understanding the impact these factors have on the delivery of heart attack care, an evidence base is built to support the various clinicians involved, and improve this complex process of care across Victoria.
Rheumatic Fever Follow-up Study (RhFFUS) _ Determining The Optimal Clinical Response For Minor Heart Valve Abnormalities In An Indigenous Australian Setting
Funder
National Health and Medical Research Council
Funding Amount
$1,394,792.00
Summary
Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are a major health issue for Indigenous Australians. In a previous study heart ultrasounds in Aboriginal and Torres Strait Islander children frequently showed suspicious but not diagnostic changes. RhFFUS (Rheumatic Fever Follow-Up Study) aims to see if these changes are associated with a higher risk of ARF and progression to RHD. If this is the case these high risk children could be identified earlier and offered regular antibiotics ....Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are a major health issue for Indigenous Australians. In a previous study heart ultrasounds in Aboriginal and Torres Strait Islander children frequently showed suspicious but not diagnostic changes. RhFFUS (Rheumatic Fever Follow-Up Study) aims to see if these changes are associated with a higher risk of ARF and progression to RHD. If this is the case these high risk children could be identified earlier and offered regular antibiotics to prevent this cause of heart disease.Read moreRead less
Bifunctionalised Contrast Nanoparticles For Simultaneous Diagnosis And Treatment Of Thrombosis, Vulnerable Plaques And Inflammation
Funder
National Health and Medical Research Council
Funding Amount
$412,882.00
Summary
The aim of this project is to develop bifunctionalised contrast nanoparticles which selectively target molecular markers of cardiovascular and inflammatory diseases at various states. The nanoparticles would provide an advanced imaging technique for early diagnosis of fatty tissue build up in the vessel wall and for detecting vessel blockages. The nanoparticles would also work as drug carrier that specifically brings curative drugs to the disease site for an acute treatment simultaneously with d ....The aim of this project is to develop bifunctionalised contrast nanoparticles which selectively target molecular markers of cardiovascular and inflammatory diseases at various states. The nanoparticles would provide an advanced imaging technique for early diagnosis of fatty tissue build up in the vessel wall and for detecting vessel blockages. The nanoparticles would also work as drug carrier that specifically brings curative drugs to the disease site for an acute treatment simultaneously with diagnosis.Read moreRead less
Clinical, Genetic And Psychosocial Aspects Of Sudden Cardiac Death
Funder
National Health and Medical Research Council
Funding Amount
$433,423.00
Summary
Sudden cardiac death (SCD) in the young is a tragic complication of a number of genetic heart diseases. Families must deal with profound grief and act on the genetic risk to themselves and other relatives. Clinical management can include the implantable cardioverter defibrillator (ICD) and is the only therapy proven to prevent SCD. This proposal seeks to investigate the clinical, genetic and psychosocial aspects of managing families who present following a SCD, including psychological outcomes o ....Sudden cardiac death (SCD) in the young is a tragic complication of a number of genetic heart diseases. Families must deal with profound grief and act on the genetic risk to themselves and other relatives. Clinical management can include the implantable cardioverter defibrillator (ICD) and is the only therapy proven to prevent SCD. This proposal seeks to investigate the clinical, genetic and psychosocial aspects of managing families who present following a SCD, including psychological outcomes of life-saving ICD therapy.Read moreRead less